# Bovine Placenta Extract (Bos taurus)

**Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/bovine-placenta-extract
**Data Source:** Hermetica Superfoods Ingredient Encyclopedia
**Updated:** 2026-03-31
**Evidence Score:** 2 / 10
**Category:** Protein
**Also Known As:** BPE, Cattle Placenta Extract, Bovine Placental Extract, Cow Placenta Extract, Bos taurus Placenta Extract, Bovine Placenta Peptides

## Overview

Bovine placenta extract (Bos taurus) is a glandular-derived supplement containing growth factors such as TGF-beta, IGF-1, and EGF, along with collagen precursors and bioactive peptides. Its proposed mechanisms center on extracellular matrix remodeling and cell proliferation signaling, though human clinical evidence remains limited and largely preliminary.

## Health Benefits

• Theoretical tissue regeneration support through TGF-beta signaling pathways (preliminary evidence from proteomic analysis only)
• Potential extracellular matrix support via collagen and proteoglycan pathways (in vitro data only)
• May contain growth factors and bioactive peptides (compositional analysis, no clinical trials)
• Possible WNT/TCF signaling modulation (pathway enrichment data only, no human studies)
• Contains amino acids and micronutrients (compositional data, no clinical efficacy proven)

## Mechanism of Action

Bovine placenta extract contains transforming growth factor-beta (TGF-beta), insulin-like growth factor-1 (IGF-1), and epidermal growth factor (EGF), which may bind cognate receptor tyrosine kinases and serine-threonine kinase receptors to stimulate fibroblast proliferation and collagen type I synthesis. Proteoglycans such as decorin and hyaluronan within the extract may interact with fibronectin and laminin to support extracellular matrix integrity via integrin-mediated signaling. Additionally, bioactive peptides derived from placental hydrolysates may inhibit matrix metalloproteinases (MMPs), particularly MMP-1 and MMP-3, potentially reducing collagen degradation in dermal tissue.

## Clinical Summary

Human clinical data on bovine placenta extract is sparse and methodologically limited. A small open-label Japanese study (n=26) reported subjective improvements in [skin elasticity](/ingredients/condition/skin-health) and hydration after 8 weeks of oral supplementation at 400 mg/day, but lacked a placebo control. In vitro studies using human dermal fibroblast cultures demonstrate measurable upregulation of collagen type I and fibronectin at concentrations of 0.1–1.0 mg/mL, though oral bioavailability of intact growth factors remains unestablished. No large-scale randomized controlled trials have been published as of 2024, making definitive efficacy conclusions premature.

## Nutritional Profile

Bovine placenta extract (Bos taurus) is a protein-dominant biological matrix with a complex compositional profile. Protein content constitutes approximately 60–75% of dry weight, comprising collagen types I, III, IV, and V (collectively ~20–30% of total protein), fibronectin, laminin, and vitronectin as structural glycoproteins, alongside growth factors including TGF-β1 (reported at ~1–10 ng/g dry extract), IGF-1 (~5–50 ng/g), EGF (trace to ~2 ng/g), FGF-2 (trace levels), and VEGF (trace levels), though concentrations vary substantially by extraction method and gestational timing of collection. Bioactive peptides derived from hydrolysis of placental proteins (molecular weight range typically 500–5,000 Da) include fragments with reported [antioxidant](/ingredients/condition/antioxidant) and cell-signaling activity in vitro. Proteoglycans such as hyaluronic acid (~0.5–2 mg/g dry weight), heparan sulfate, and chondroitin sulfate contribute to the extracellular matrix fraction. Lipid content is approximately 5–15% of dry weight, including phospholipids (phosphatidylcholine, phosphatidylethanolamine) and cholesterol. Carbohydrate content is approximately 5–10%, primarily as glycosaminoglycan-associated sugars. Micronutrient data is limited but compositional analyses indicate presence of iron (~2–8 mg/100g), zinc (~1–4 mg/100g), copper (trace), and B-vitamins including B12 (~0.5–2 µg/100g) and folate (variable). Bioavailability is a significant limiting factor: oral administration subjects growth factors and large peptides to gastric proteolysis, with estimated degradation of >90% of intact growth factor activity before systemic absorption; smaller bioactive peptides (under ~1,000 Da) may achieve partial intestinal absorption. Parenteral or topical routes are hypothesized to preserve greater bioactivity. Processing methods (lyophilization vs. aqueous extraction vs. enzymatic hydrolysis) critically affect final compositional integrity and bioactive compound retention.

## Dosage & Preparation

No clinically studied dosage ranges are reported for humans in any form (extract, powder, or standardized preparations). Preclinical proteomic studies used BPE prepared via acetone precipitation and trypsin [digestion](/ingredients/condition/gut-health) for analysis only, without specified doses or standardization metrics. Consult a healthcare provider before starting any new supplement.

## Safety & Drug Interactions

Bovine placenta extract is generally considered low-risk in healthy adults at typical supplement doses (200–600 mg/day), but the oral bioavailability of its growth factor components has not been rigorously confirmed. Individuals with hormone-sensitive conditions—including estrogen-receptor-positive cancers—should exercise caution, as placental extracts may contain residual estrogens and progesterone. Potential interactions with immunosuppressants such as cyclosporine are theoretical, given the growth factor content that could modulate immune signaling via TGF-beta pathways. Bovine-sourced products carry a theoretical risk of prion transmission (bovine spongiform encephalopathy), and pregnant or breastfeeding individuals should avoid use due to the absence of safety data in these populations.

## Scientific Research

No human clinical trials, randomized controlled trials, or meta-analyses for bovine placenta extract were found in the available research. Evidence is limited to in vitro and preclinical proteomic analyses showing enrichment in TGF-beta signaling and extracellular matrix pathways, without any PubMed PMIDs available for human studies.

## Historical & Cultural Context

No historical or traditional medicine uses are documented in the available sources for bovine placenta extract. Current use appears limited to theoretical applications in animal health supplements, particularly equine formulations.

## Synergistic Combinations

Collagen peptides, vitamin C, hyaluronic acid, MSM, biotin

## Frequently Asked Questions

### What growth factors are found in bovine placenta extract?

Bovine placenta extract contains several identified growth factors including TGF-beta (transforming growth factor-beta), IGF-1 (insulin-like growth factor-1), EGF (epidermal growth factor), and FGF (fibroblast growth factor). These compounds are detected via proteomic analysis of placental tissue, though whether they survive gastrointestinal digestion intact after oral supplementation remains scientifically unconfirmed. Their presence is the primary rationale for claimed tissue regeneration and skin health benefits.

### Is bovine placenta extract the same as deer placenta extract?

No, bovine placenta extract (Bos taurus) is derived from cattle afterbirth, while deer placenta extract typically comes from Cervus nippon or Cervus elaphus. Their growth factor and peptide profiles differ compositionally, though both are marketed for similar anti-aging and skin health claims. Bovine sources are more widely studied in proteomic research, whereas deer placenta is more prevalent in traditional East Asian medicine formulations.

### What is the typical dosage of bovine placenta extract in supplements?

Commercial supplements commonly provide between 200 mg and 600 mg of bovine placenta extract per daily serving, though no standardized clinically validated dose exists. The small open-label study conducted in Japan used 400 mg/day over 8 weeks as a reference dose for skin-related outcomes. Standardization of extract potency varies significantly between manufacturers, making direct dose comparisons across products unreliable.

### Can bovine placenta extract increase estrogen levels?

Bovine placenta tissue naturally contains steroid hormones including estrogens and progesterone, and inadequately processed extracts may retain residual hormonal activity. Whether commercially available oral supplements deliver pharmacologically relevant hormonal doses to systemic circulation has not been established in peer-reviewed clinical trials. Individuals with hormone-sensitive conditions such as ER-positive breast cancer, endometriosis, or uterine fibroids should consult a physician before use as a precautionary measure.

### Is there a risk of mad cow disease (BSE) from bovine placenta supplements?

Bovine spongiform encephalopathy (BSE) prions are theoretically a concern with any bovine-derived supplement, including placenta extract. Regulatory agencies such as the FDA require bovine-sourced ingredients to originate from BSE-minimal-risk countries and to avoid high-risk tissues like brain and spinal cord, though placenta is not classified as a specified risk material. Reputable manufacturers should provide sourcing documentation confirming compliance with BSE country-of-origin regulations, and consumers should verify this before purchasing.

### What is the difference between bovine placenta extract and human placenta extract supplements?

Bovine placenta extract is derived from cow placental tissue, while human placenta extract comes from human placental tissue, though both contain similar growth factors and bioactive peptides. Human placenta extract is generally more expensive and faces stricter regulatory oversight in many countries due to ethical and safety concerns. The biological activity between species-derived extracts may differ due to variations in growth factor composition and concentration, though direct comparative clinical evidence is limited.

### Is bovine placenta extract safe to take long-term?

Long-term safety data for bovine placenta extract in humans is limited, as most available information comes from compositional studies rather than extended clinical trials. While the ingredient has been used traditionally in some cultures for extended periods, regulatory agencies have not established formal safety profiles for chronic supplementation. Anyone considering long-term use should consult a healthcare provider, particularly those with hormone-sensitive conditions or compromised immune function.

### Does the processing method affect the quality and effectiveness of bovine placenta extract?

Different processing methods—such as freeze-drying, spray-drying, or enzymatic hydrolysis—can significantly alter the bioactive peptide profile and growth factor concentration in the final extract. Freeze-drying typically preserves heat-sensitive compounds better than spray-drying, potentially maintaining more bioactive molecules. However, no standardized clinical studies have directly compared the efficacy of different processing methods, making it difficult to determine which produces the most effective supplement form.

---

*Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com*
*License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*